J.W. Cole Advisors, Inc. Vericel Corp Transaction History
J.W. Cole Advisors, Inc.
- $2.09 Billion
- Q2 2024
A detailed history of J.W. Cole Advisors, Inc. transactions in Vericel Corp stock. As of the latest transaction made, J.W. Cole Advisors, Inc. holds 7,100 shares of VCEL stock, worth $341,013. This represents 0.02% of its overall portfolio holdings.
Number of Shares
7,100
Previous 7,100
-0.0%
Holding current value
$341,013
Previous $369,000
11.92%
% of portfolio
0.02%
Previous 0.02%
Shares
6 transactions
Others Institutions Holding VCEL
# of Institutions
268Shares Held
48.4MCall Options Held
91.1KPut Options Held
39.8K-
Black Rock Inc. New York, NY8.06MShares$387 Million0.01% of portfolio
-
Brown Capital Management LLC Baltimore, MD4.42MShares$212 Million4.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.44MShares$165 Million0.0% of portfolio
-
State Street Corp Boston, MA2.48MShares$119 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.04MShares$98 Million1.42% of portfolio
About Vericel Corp
- Ticker VCEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,178,000
- Market Cap $2.27B
- Description
- Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...